MIRM - Mirum Pharmaceuticals, Inc.
NEXT EARNINGS:
Feb 25, 2026
(today)
EPS Est: $0.02
|
Rev Est: $141.8M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$112.60
DETAILS
HIGH:
$140.00
LOW:
$95.00
MEDIAN:
$105.50
CONSENSUS:
$112.60
UPSIDE:
4.76%
Market Cap:
5.55B
Volume:
613,462
Avg Volume:
757,341
52 Week Range:
36.88-109.28
Sector:
Healthcare
Industry:
Biotechnology
Beta:
0.50
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
334
IPO Date:
2019-07-18
EPS (TTM):
-1.85
P/E Ratio:
-22.35
Revenue (TTM):
336.89M
Total Assets:
670.75M
Total Debt:
317.76M
Cash & Equiv:
222.50M
Rev Growth (5Y):
160.1%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-13.3%
Debt/Equity:
1.41
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-04 | $0.05 | $-0.10 | +150.0% | $133.0M | $140.9M | -5.6% |
| 2025-08-06 | $-0.12 | $-0.31 | +61.3% | $127.8M | $130.1M | -1.8% |
| 2025-05-07 | $-0.30 | $-0.39 | +23.1% | $111.6M | $98.4M | +13.4% |
| 2025-02-26 | $-0.49 | $-0.27 | -81.5% | $99.4M | $96.6M | +2.9% |
| 2024-11-12 | $-0.30 | $-0.45 | +33.3% | $90.4M | $95.4M | -5.3% |
| 2024-08-07 | $-0.52 | $-0.48 | -8.3% | $77.9M | $75.2M | +3.5% |
| 2024-05-08 | $-0.54 | $-0.40 | -35.0% | $69.2M | $70.2M | -1.4% |
| 2024-02-28 | $-0.66 | $-0.34 | -94.1% | $69.6M | $67.8M | +2.6% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|
| Revenue | 336.89M | 186.37M | 77.06M | 19.14M | 0 | 0 | 0 |
| Net Income | (87.94M) | (163.41M) | (135.66M) | (83.99M) | (103.27M) | (52.55M) | (17.35M) |
| EPS | -1.85 | -4.00 | -4.01 | -2.77 | -4.09 | -2.29 | -0.75 |
| Total Assets | 670.75M | 646.62M | 352.91M | 294.65M | 240.86M | 146.71M | 51.98M |
| Total Debt | 317.76M | 308.14M | 2.19M | 2.61M | 3.26M | 3.65M | 0 |
| Cash & Equivalents | 222.50M | 286.33M | 28.00M | 31.34M | 142.09M | 11.97M | 51.96M |
| Operating Cash Flow | 10.32M | (70.94M) | (120.14M) | (132.76M) | (89.08M) | (39.36M) | (373,000) |
| Free Cash Flow | 9.33M | (91.05M) | (120.41M) | (151.78M) | (89.30M) | (39.64M) | (7.87M) |
| FCF per Share | 0.20 | -2.23 | -3.56 | -5.01 | -3.54 | -1.72 | -0.34 |
| Book Value | 225.64M | 248.67M | 142.04M | 120.21M | 172.09M | 130.35M | (10.32M) |
| Cash & ST Investments | 280.31M | 286.33M | 151.72M | 156.54M | 231.82M | 116.66M | 51.96M |
| ROC Equity | -0.39 | -0.66 | -0.96 | -0.70 | -0.60 | -0.40 | N/A |